Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Lewis Au(Royal Marsden NHS Foundation Trust), Mariam Jamal‐Hanjani(CRUK Lung Cancer Centre of Excellence), Steve Hazell(Royal Marsden NHS Foundation Trust), Eleanor Carlyle(Royal Marsden NHS Foundation Trust), Kim Edmonds(Royal Marsden NHS Foundation Trust), Gordon Beattie(Cancer Research UK), Nicos Fotiadis(Royal Marsden NHS Foundation Trust), Mary Mangwende(Royal Marsden NHS Foundation Trust), Ignazio Puccio(University College Hospital), Kevin Litchfield(Cancer Research UK), Désirée Schnidrig(The Francis Crick Institute), Roberto Salgado(Institut Jules Bordet), Ehsan Ghorani(CRUK Lung Cancer Centre of Excellence), Sarah Sarker(Royal Marsden NHS Foundation Trust), Lisa Pickering(Royal Marsden Hospital), Annika Fendler(The Francis Crick Institute), Emine Hatipoglu(Royal Marsden NHS Foundation Trust), Elaine Borg(University College Hospital), Kim Dhillon(University College Hospital), Mary Falzon, José I. López(BioCruces Health research Institute), Mariana Werner Sunderland(London Cancer), Tom Lund(Royal Marsden Hospital), Anna Green(St Thomas' Hospital), Marc Robert de Massy(Cancer Research UK), Andrew J.S. Furness(Cancer Research UK), Andrew Rowan(Cancer Institute (WIA)), Robert M. Mason(Royal Marsden NHS Foundation Trust), Fiona Byrne(The Francis Crick Institute), Ayse U. Akarca(Cancer Research UK), David A. Moore(The Francis Crick Institute), Kroopa Joshi(Royal Marsden NHS Foundation Trust), Imran Uddin(Cancer Research UK), Miriam Mitchison(Royal London Hospital), Jan Attig(The Francis Crick Institute), Pablo D. Becker(United Therapeutics (United Kingdom)), Karla Lingard(Royal Marsden NHS Foundation Trust), Scott T.C. Shepherd(Royal Marsden NHS Foundation Trust), Charlotte Spencer(The Francis Crick Institute), R. Houston Thompson(The Francis Crick Institute), Ula Mahadeva(St Thomas' Hospital), Ian Proctor, William Yang(University College Hospital), James L. Reading(CRUK Lung Cancer Centre of Excellence), Hang Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), David Nicol(Royal Stoke University Hospital), Lyra Del Rosario(Royal Marsden NHS Foundation Trust), Stuart Horswell(The Francis Crick Institute), Marcos Duran Vasquez(Cancer Research UK), Teresa Marafioti(Cancer Research UK)
Cited by 266
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k